Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,088 | 19,226 | 29,332 | 133,880 | 181,045 |
| Receivables | 206,616 | 202,717 | 177,953 | 154,726 | 133,758 |
| Inventories | 46,821 | 49,265 | 53,214 | 33,979 | 32,184 |
| Other current assets | 12,215 | 10,740 | 12,029 | 0 | 0 |
| TOTAL | $303,868 | $296,907 | $286,548 | $350,241 | $390,537 |
| Non-Current Assets | |||||
| PPE Net | 138,824 | 125,418 | 115,295 | 104,223 | 98,784 |
| Intangibles | 174,286 | 172,058 | 171,008 | 162,877 | 155,120 |
| Other Non-Current Assets | 44,032 | 42,133 | 38,022 | 32,900 | 13,725 |
| TOTAL | $357,142 | $339,609 | $324,325 | $300,000 | $267,629 |
| Total Assets | $661,010 | $636,516 | $610,873 | $650,241 | $658,166 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 147,543 | N/A |
| Accounts payable and accrued liabilities | 50,821 | 55,168 | 57,639 | 44,710 | 33,009 |
| Accrued Expenses | 38,969 | 34,919 | 34,028 | 28,621 | 24,368 |
| TOTAL | $135,775 | $140,510 | $143,195 | $280,274 | $106,408 |
| Non-Current Liabilities | |||||
| Long Term Debt | 267,002 | 234,033 | 223,075 | 8,864 | N/A |
| Deferred Revenues | 10,887 | 13,868 | 19,154 | 20,181 | 16,528 |
| Other Non-Current Liabilities | 79,591 | 66,742 | 57,457 | 52,803 | 52,705 |
| TOTAL | $355,846 | $308,093 | $286,023 | $77,627 | $270,000 |
| Total Liabilities | $491,621 | $448,603 | $429,218 | $357,901 | $376,408 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,856 | 46,226 | 47,621 | 45,067 | 44,617 |
| Common Shares | 1,203 | 1,233 | 1,262 | 1,397 | 1,430 |
| Retained earnings | 415,930 | 361,255 | 283,660 | 536,991 | 469,454 |
| Other shareholders' equity | -2,744 | -2,575 | 1,607 | -3,048 | -3,845 |
| TOTAL | $169,389 | $187,913 | $181,655 | $292,340 | $281,758 |
| Total Liabilities And Equity | $661,010 | $636,516 | $610,873 | $650,241 | $658,166 |